MD Meymac
Originally founded by Bristol Myers Squibb in 1988, the production site in Meymac was acquired by the Prange Pharma Group in 2024. Our facility combines deep pharmaceutical expertise with advanced technologies to support your oral dosage form projects. We offer trustworthy partnerships based on reliability, flexibility, and a strong commitment to our customers.

2 bn
tablets
per annum

400 mio.
capsules
per annum

50 mio.
sachets
per annum

60 mio.
blister
per annum

250k
bottles
per annum

Our Vision and Mission
At MD Meymac, we strive to build long-term, reliable, and sustainable partnerships with our customers. Based on our strategy, our guiding principles reflect our commitment to delivering the highest quality of our products, while fostering growth with both existing and new customers.
